Elektrofi is a preclinical-stage company dedicated to redefining the standard of drug delivery by transforming the patient experience.
Elektrofi has raised $112.3M in total funding. The most recent round was Series C. The last funding was announced in August 2024.
Elektrofi's investors include National Science Foundation, General Catalyst, RA Capital Management, Catalio Capital Management, SR One.
Elektrofi is headquartered in Boston, United States.
Elektrofi is a preclinical-stage company dedicated to redefining the standard of drug delivery by transforming the patient experience.
Elektrofi is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Elektrofi — Funding & Investors." VCBacked, August 22, 2024, https://www.vcbacked.co/company/elektrofi. Accessed July 19, 2026.
VCBacked. (2024). Elektrofi — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/elektrofi
{{cite web |title=Elektrofi — Funding & Investors |url=https://www.vcbacked.co/company/elektrofi |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated